Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.57	12.22	11.74	6.59	7.73	5.44
Short-Term Investments	-	-	-	0.05	0.03	0.03
Trading Asset Securities	-	-	-	-	0.03	0.03
Cash & Short-Term Investments	11.57	12.22	11.74	6.64	7.79	5.49
Cash Growth	-17.68%	4.05%	76.87%	-14.72%	41.69%	171.63%
Accounts Receivable	38.7	37.35	28.25	29.95	31.63	30.81
Other Receivables	-	0.04	-	0	-	-
Receivables	38.7	37.39	28.25	29.95	31.63	30.81
Inventory	13.62	13.45	8.34	10.41	10.88	14.76
Prepaid Expenses	-	0.35	0.31	0.51	0.4	0.73
Other Current Assets	3.37	2.38	2.89	3.1	2.22	3.33
Total Current Assets	67.26	65.79	51.54	50.61	52.91	55.12
Property, Plant & Equipment	29.45	28.77	25.9	27.13	25.48	27.47
Long-Term Investments	14.61	14.23	7.24	6.42	3.22	0.7
Other Intangible Assets	2.86	2.67	1.8	1.55	1.52	3.04
Long-Term Deferred Tax Assets	0.55	0.53	0.4	0.28	0.27	0.2
Other Long-Term Assets	2.61	2.6	2.27	0.32	0.32	0.37
Total Assets	117.33	114.59	89.15	86.32	83.72	86.89
Accounts Payable	6.93	7.89	3.69	3.92	6.56	5.11
Accrued Expenses	-	4	3.58	2.33	1.32	1.99
Short-Term Debt	1.61	-	0.46	0.52	0.65	0.78
Current Portion of Long-Term Debt	-	0.72	0.61	1.13	0.69	0.57
Current Portion of Leases	0.46	0.4	0.3	0.48	0.36	0.55
Current Income Taxes Payable	3.83	3.67	1.29	2.42	2.67	1.66
Other Current Liabilities	6.86	2.61	2.07	1.5	1.46	2.3
Total Current Liabilities	19.69	19.3	12	12.32	13.7	12.97
Long-Term Leases	0.21	0.21	0.14	0.33	0.49	0.72
Long-Term Unearned Revenue	0.52	0.52	0.29	-	-	-
Pension & Post-Retirement Benefits	6.46	6.36	5.12	4.79	4.3	4.64
Total Liabilities	26.88	26.39	17.55	17.44	18.49	18.32
Common Stock	18	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72	3.72
Retained Earnings	53.72	51.58	42.83	39.6	34.9	29.89
Comprehensive Income & Other	13.87	13.82	6.04	6.52	7.65	14.87
Total Common Equity	89.31	87.11	70.6	67.84	64.27	66.47
Minority Interest	1.15	1.08	1.01	1.04	0.96	2.1
Shareholders' Equity	90.46	88.2	71.61	68.88	65.23	68.57
Total Liabilities & Equity	117.33	114.59	89.15	86.32	83.72	86.89
Total Debt	2.28	1.32	1.51	2.47	2.18	2.63
Net Cash (Debt)	9.28	10.9	10.23	4.17	5.6	2.86
Net Cash Growth	-30.04%	6.53%	145.52%	-25.64%	95.69%	-
Net Cash Per Share	0.26	0.30	0.28	0.12	0.16	0.08
Filing Date Shares Outstanding	17.99	36	36	36	36	36
Total Common Shares Outstanding	17.99	36	36	36	36	36
Working Capital	47.56	46.49	39.53	38.28	39.2	42.16
Book Value Per Share	4.97	2.42	1.96	1.88	1.79	1.85
Tangible Book Value	86.45	84.44	68.8	66.29	62.75	63.43
Tangible Book Value Per Share	4.81	2.35	1.91	1.84	1.74	1.76
Land	-	10.43	9.49	10.63	9.24	8.31
Buildings	-	16.73	15.42	15.64	15.73	16.34
Machinery	-	35.71	30.8	29.47	28.78	31.82
Construction In Progress	-	0.01	-	-	-	-